Page last updated: 2024-11-02

palmidrol and Diabetic Neuropathies

palmidrol has been researched along with Diabetic Neuropathies in 8 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research Excerpts

ExcerptRelevanceReference
"The management of the associated neuropathic pain remains difficult to treat."3.11A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. ( Pickering, E; Rao, A; Steadman, KJ; Steels, EL; Vitetta, L, 2022)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Pickering, E1
Steels, EL1
Steadman, KJ1
Rao, A1
Vitetta, L1
Semprini, R1
Martorana, A1
Ragonese, M1
Motta, C1
Pieralice, S1
Vari, R1
Minutolo, A1
Maurizi, AR1
Fioriti, E1
Napoli, N1
Pozzilli, P1
Manfrini, S1
Maddaloni, E1
Impellizzeri, D1
Peritore, AF1
Cordaro, M1
Gugliandolo, E1
Siracusa, R1
Crupi, R1
D'Amico, R1
Fusco, R1
Evangelista, M1
Cuzzocrea, S1
Di Paola, R1
Donvito, G1
Bettoni, I1
Comelli, F1
Colombo, A1
Costa, B1
Déciga-Campos, M1
Ortíz-Andrade, R1
Silva, M1
Martins, D1
Charrua, A1
Piscitelli, F1
Tavares, I1
Morgado, C1
Di Marzo, V2
Darmani, NA1
Izzo, AA1
Degenhardt, B1
Valenti, M1
Scaglione, G1
Capasso, R1
Sorrentini, I1

Reviews

1 review available for palmidrol and Diabetic Neuropathies

ArticleYear
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies.
    Neuropharmacology, 2005, Volume: 48, Issue:8

    Topics: Amides; Animals; Cannabinoid Receptor Modulators; Clinical Trials as Topic; Colitis, Ulcerative; Dia

2005

Trials

1 trial available for palmidrol and Diabetic Neuropathies

ArticleYear
A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain.
    Inflammopharmacology, 2022, Volume: 30, Issue:6

    Topics: Australia; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Inflammation; Neuralgia; Treatm

2022

Other Studies

6 other studies available for palmidrol and Diabetic Neuropathies

ArticleYear
Observational clinical and nerve conduction study on effects of a nutraceutical combination on painful diabetic distal symmetric sensory-motor neuropathy in patients with diabetes type 1 and type 2.
    Minerva medica, 2018, Volume: 109, Issue:5

    Topics: Abietanes; Adult; Amides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathie

2018
Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy.
    Endocrine, 2019, Volume: 66, Issue:2

    Topics: Adult; Aged; Amides; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Diabetic Neuropathies; Ethanola

2019
The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:10

    Topics: Amides; Analgesics; Animals; Anti-Inflammatory Agents; Apoptosis; Cytokines; Diabetic Neuropathies;

2019
Palmitoylethanolamide relieves pain and preserves pancreatic islet cells in a murine model of diabetes.
    CNS & neurological disorders drug targets, 2015, Volume: 14, Issue:4

    Topics: Amides; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ethanolamines;

2015
Enhancement of Antihyperalgesia by the Coadministration of N-palmitoylethanolamide and Acetaminophen in Diabetic Rats.
    Drug development research, 2015, Volume: 76, Issue:5

    Topics: Acetaminophen; Amides; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies;

2015
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
    Neuropharmacology, 2016, Volume: 107

    Topics: Amides; Amidohydrolases; Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Capsaicin; Chronic Pa

2016